Innoviva, Inc. (INVA) stock: analyst price target and their real reliability

Aug 7, 26

▲ Overweight · 🎯$34

Price at call : $20.51 — upside +66%

Today : $20.74 — upside +64%

🎯 on INVA : 60% (5 calls matureds) · 📊 on Health : 50% · +13.4% (168 calls)

in progress (365j)
matures : Aug 7, 27

Jun 22, 26

▲ Buy · 🎯$42

Price at call : $23.55 — upside +78%

Today : $20.74 — upside +103%

🎯 on INVA : no call matured yet · 📊 on Health : 47.1% · +20.0% (68 calls)

in progress (365j)
matures : Jun 22, 27

Jun 1, 26

▲ Buy · 🎯$46

Price at call : $21.51 — upside +114%

Today : $20.74 — upside +122%

🎯 on INVA : 100% (2 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)

in progress (365j)
matures : Jun 1, 27

May 26, 26

▲ Buy · 🎯$42

Price at call : $22.68 — upside +85%

Today : $20.74 — upside +103%

🎯 on INVA : no call matured yet · 📊 on Health : 47.1% · +20.0% (68 calls)

in progress (365j)
matures : May 26, 27

May 7, 26

▲ Buy · 🎯$42

Price at call : $22.8 — upside +84%

Today : $20.74 — upside +103%

🎯 on INVA : no call matured yet · 📊 on Health : 47.1% · +20.0% (68 calls)

in progress (365j)
matures : May 7, 27

Feb 26, 26

▲ Buy · 🎯$35

Price at call : $23.54 — upside +49%

Today : $20.74 — upside +69%

🎯 on INVA : no call matured yet · 📊 on Health : 47.1% · +20.0% (68 calls)

in progress (365j)
matures : Feb 26, 27

Feb 17, 26

▲ Buy · 🎯$35

Price at call : $23.85 — upside +47%

Today : $20.74 — upside +69%

🎯 on INVA : no call matured yet · 📊 on Health : 47.1% · +20.0% (68 calls)

in progress (365j)
matures : Feb 17, 27

Dec 16, 25

▲ Buy · 🎯$46

Price at call : $19.92 — upside +131%

Today : $20.74 — upside +122%

🎯 on INVA : 100% (2 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)

in progress (365j)
matures : Dec 16, 26

See the other 29 calls, newest to oldest

Nov 6, 25

▲ Overweight · 🎯$31

Price at call : $20.86 — upside +49%

Today : $20.74 — upside +49%

🎯 on INVA : 60% (5 calls matureds) · 📊 on Health : 50% · +13.4% (168 calls)

in progress (365j)
matures : Nov 6, 26

Goldman Sachs ↗

Sep 30, 25

▼ Sell · 🎯$17

Price at call : $18.25 — upside -7%

Today : $20.74 — upside -18%

Expected -7% · Actual +16% · Reason (≤ −15%) : ✗ No

🎯 on INVA : 0% (1 call matured) · 📊 on Health : 51.9% · +5.8% (104 calls)

-16.2%

stock +16% · XLV +21%

matured Sep 30, 26

Oppenheimer ↗

Aug 11, 25

▲ Outperform · 🎯$35

Price at call : $19.65 — upside +78%

Today : $20.74 — upside +69%

Expected +78% · Actual +6% · Reason (≥ +15%) : ✗ No

🎯 on INVA : 100% (1 call matured) · 📊 on Health : 47.4% · +5.9% (95 calls)

+5.6%

stock +6% · XLV +29%

matured Aug 11, 26

Aug 11, 25

▲ Buy · 🎯$45

Price at call : $19.65 — upside +129%

Today : $20.74 — upside +117%

Expected +129% · Actual +6% · Reason (≥ +15%) : ✗ No

🎯 on INVA : 100% (2 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)

+5.6%

stock +6% · XLV +29%

matured Aug 11, 26

Jul 14, 25

▲ Buy · 🎯$40

Price at call : $19.58 — upside +104%

Today : $20.74 — upside +93%

Expected +104% · Actual +11% · Reason (≥ +15%) : ✗ No

🎯 on INVA : 100% (2 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)

+11.0%

stock +11% · XLV +17%

matured Jul 14, 26

Jul 11, 25

▲ Overweight · 🎯$26

Price at call : $18.77 — upside +39%

Today : $20.74 — upside +25%

Expected +39% · Actual +18% · Reason (≥ +15%) : ✓ Yes

🎯 on INVA : 60% (5 calls matureds) · 📊 on Health : 50% · +13.4% (168 calls)

+18.3%

stock +18% · XLV +19%

matured Jul 11, 26

Scotiabank ↗

Mar 7, 25

▲ Sector Outperform · 🎯$55

Price at call : $17.48 — upside +215%

Today : $20.74 — upside +165%

Expected +215% · Actual +28% · Reason (≥ +15%) : ✓ Yes

🎯 on INVA : 100% (1 call matured) · 📊 on Health : 80% · +13.8% (5 calls)

+27.7%

stock +28% · XLV +4%

matured Mar 7, 26

Aug 1, 24

▲ Overweight

Actual -3% · Reason (≥ +15%) : ✗ No

🎯 on INVA : 60% (5 calls matureds) · 📊 on Health : 50% · +13.4% (168 calls)

-2.6%

stock -3% · XLV -12%

matured Aug 1, 25

Jul 30, 24

▲ Overweight

Actual -4% · Reason (≥ +15%) : ✗ No

🎯 on INVA : 60% (5 calls matureds) · 📊 on Health : 50% · +13.4% (168 calls)

-3.6%

stock -4% · XLV -13%

matured Jul 30, 25

Jun 20, 24

▲ Overweight

Actual +31% · Reason (≥ +15%) : ✓ Yes

🎯 on INVA : 60% (5 calls matureds) · 📊 on Health : 50% · +13.4% (168 calls)

+30.9%

stock +31% · XLV -10%

matured Jun 20, 25

Jun 18, 24

▲ Overweight

Actual +32% · Reason (≥ +15%) : ✓ Yes

🎯 on INVA : 60% (5 calls matureds) · 📊 on Health : 50% · +13.4% (168 calls)

+32.3%

stock +32% · XLV -9%

matured Jun 18, 25

May 10, 23

▲ Buy · 🎯$22.5

Price at call : $12.2 — upside +84%

Today : $20.74 — upside +8%

Expected +84% · Actual +25% · Reason (≥ +15%) : ✓ Yes

🎯 on INVA : 75% (4 calls matureds) · 📊 unranked overall

+25.3%

stock +25% · XLV +8%

matured May 9, 24

Apr 20, 23

▲ Buy · 🎯$22.5

Price at call : $11.84 — upside +90%

Today : $20.74 — upside +8%

Expected +90% · Actual +26% · Reason (≥ +15%) : ✓ Yes

🎯 on INVA : 75% (4 calls matureds) · 📊 unranked overall

+26.3%

stock +26% · XLV +4%

matured Apr 19, 24

Goldman Sachs ↗

Mar 3, 23

■ Neutral neutral · not a buy · 🎯$13

Price at call : $11.02 — gap to target +18%

Today : $20.74 — gap to target -37%

🎯 on INVA : 0% (1 call matured) · 📊 on Health : 51.9% · +5.8% (104 calls)

in progress (365j)
matures : Mar 2, 24

Mar 3, 23

▼ Underweight · 🎯$10

Price at call : $11.02 — upside -9%

Today : $20.74 — upside -52%

Expected -9% · Actual +38% · Reason (≤ −15%) : ✗ No

🎯 on INVA : 56% (9 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)

-38.5%

stock +38% · XLV +13%

matured Mar 2, 24

Mar 3, 23

▲ Buy · 🎯$22.5

Price at call : $10.99 — upside +105%

Today : $20.74 — upside +8%

Expected +105% · Actual +39% · Reason (≥ +15%) : ✓ Yes

🎯 on INVA : 75% (4 calls matureds) · 📊 unranked overall

+38.9%

stock +39% · XLV +13%

matured Mar 2, 24

Jan 24, 23

▼ Underweight · 🎯$13

Price at call : $12.43 — upside +5%

Today : $20.74 — upside -37%

Expected +5% · Actual +31% · Reason (≤ −15%) : ✗ No

🎯 on INVA : 56% (9 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)

-31.5%

stock +31% · XLV +4%

matured Jan 24, 24

Oct 13, 22

▼ Underweight · 🎯$14

Price at call : $13.37 — upside +5%

Today : $20.74 — upside -32%

Expected +5% · Actual -0% · Reason (≤ −15%) : ✗ No

🎯 on INVA : 56% (9 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)

+0.4%

stock -0% · XLV +4%

matured Oct 13, 23

Aug 8, 22

▼ Underweight · 🎯$13

Price at call : $14.37 — upside -10%

Today : $20.74 — upside -37%

Expected -10% · Actual -5% · Reason (≤ −15%) : ✗ No

🎯 on INVA : 56% (9 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)

+4.9%

stock -5% · XLV +3%

matured Aug 8, 23

Goldman Sachs ↗

Jul 20, 22

■ Neutral neutral · not a buy · 🎯$16

Price at call : $14.41 — gap to target +11%

Today : $20.74 — gap to target -23%

🎯 on INVA : 0% (1 call matured) · 📊 on Health : 51.9% · +5.8% (104 calls)

in progress (365j)
matures : Jul 20, 23

Jul 15, 22

▼ Underweight · 🎯$12

Price at call : $14.51 — upside -17%

Today : $20.74 — upside -42%

Expected -17% · Actual -14% · Reason (≤ −15%) : ✗ No

🎯 on INVA : 56% (9 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)

+14.1%

stock -14% · XLV +3%

matured Jul 15, 23

Apr 12, 22

▼ Underweight · 🎯$13

Price at call : $19.3 — upside -33%

Today : $20.74 — upside -37%

Expected -33% · Actual -37% · Reason (≤ −15%) : ✓ Yes

🎯 on INVA : 56% (9 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)

+36.8%

stock -37% · XLV -3%

matured Apr 12, 23

Feb 23, 22

▼ Underweight · 🎯$12

Price at call : $19.17 — upside -37%

Today : $20.74 — upside -42%

Expected -37% · Actual -37% · Reason (≤ −15%) : ✓ Yes

🎯 on INVA : 56% (9 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)

+36.6%

stock -37% · XLV +3%

matured Feb 23, 23

Feb 11, 22

▲ Buy · 🎯$28

Price at call : $19.25 — upside +45%

Today : $20.74 — upside +35%

Expected +45% · Actual -36% · Reason (≥ +15%) : ✗ No

🎯 on INVA : 75% (4 calls matureds) · 📊 unranked overall

-36.0%

stock -36% · XLV +3%

matured Feb 11, 23

Nov 11, 20

▼ Underweight · 🎯$10

Price at call : $10.83 — upside -8%

Today : $20.74 — upside -52%

Expected -8% · Actual +65% · Reason (≤ −15%) : ✗ No

🎯 on INVA : 56% (9 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)

-64.5%

stock +65% · XLV +20%

matured Nov 11, 21

Stifel ↗

Apr 27, 18

■ Hold neutral · not a buy · 🎯$16

Price at call : $14.23 — gap to target +12%

Today : $20.74 — gap to target -23%

🎯 on INVA : no call matured yet · 📊 on Health : 44.3% · +6.0% (97 calls)

in progress (365j)
matures : Apr 27, 19

Deutsche Bank ↗

Nov 20, 17

■ Hold neutral · not a buy · 🎯$13

Price at call : $13.17 — gap to target -1%

Today : $20.74 — gap to target -37%

🎯 on INVA : no call matured yet · 📊 on Health : 33.9% · -7.0% (56 calls)

in progress (365j)
matures : Nov 20, 18